Whitepapers
Pharma white papers on contemporary issues, technologies, research, etc. are presented in this section to enable the readers with rich information and knowledge. This section provides white papers related to all the spheres of the pharma industry.
Comprehensive Guide to Establishing and Managing Clinical Operations for Successful Biotech Clinical Trials
In the biotechnology industry clinical trials are the cornerstone of bringing innovative therapies to patients However executing successful trials requires meticulous planning efficient operations and strict adherence to regulatory standards This comprehensive guide provides a stepbystep approach to establishing and managing clinical operations for biotech clinical trials
AtlasGEN Novel Drug Designer: Design Clinical Success Into New Drug Discovery from Day One
Designing a new drug molecule to fight diseases and pathogens is extremely difficult time consuming and expensive Even when a diseases pathway is clearly understood and a target
A Comprehensive Guide to Responsible AI for Life Sciences
From latestage clinical development through commercialization life sciences teams depend on highquality evidence from a vast array of sources to discover diagnose and improve treatments and health outcomes
Introduction to EU Regulatory Affairs
In the European Union a network of approximately regulatory authorities from the European Economic Area countries the European Commission and European Medicines Agency form the basis of the European regulatory system
Six Reasons Why Direct Patient Support is a ‘must have’ for Your Clinical Trials
With a growing and ageing global population an efficient and continuous drug development pipeline is crucial in the biopharmaceutical industrys ongoing mission to keep people well
Pharmacovigilance Challenges in Early Phase Clinical Trials
Early phase clinical trials have their own unique challenges as they play a vital role in drug development During early trials we aim to evaluate the safety tolerability
The Reckoning of Antimicrobial Resistance, A new biological frontier
The life sciences sector is permanently evolving but a moment of reckoning has arriveda moment that compels us at Cavenagh Health to address a real global threat that resonates beyond
Roadmap to Biomarker Discovery: Innovations, Opportunities, and Breakthroughs
Biomarkers are indicators of homeostasis disease states or pharmacological interventions An ideal biomarker must be bina present or absent quantifiable in tissues cells body fluids or in simple physiological parameters
How Prancer RTSM® Enables Complex Studies - The Complex Study is Here to Stay
Clinical researchers are becoming much more creative in how they explore possible treatments They are leveraging more adaptive trials where phases can be combined or skipped based on positive results or where the protocol is amended to explore new treatments or disease states within the same trial
The Need For Adaptive Trial Design In Oncology Studies
Trial research needs to account for increased complexity and competition when recruiting patients in cancer studies Patients and oncologists have more choices than ever for the placement of qualified study participants Not only are treatments more specialised but the industry
